KATRD
LOGIN
- KATRD 2021 International Conference
-
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program in Detail
한국어 진행 강의입니다.
|
[Symposium 07] Lung Cancer 1 - New Applicable Biomarkers in Lung Cancer |
10:30-12:00 Crystal Ballroom 3 |
||
|---|---|---|---|
| Chair | Sei Hoon Yang (Wonkwang University, Korea) | ||
| 10:30-11:00 | SY 7-1 |
Navigating the Evolving NSCLC 1L Treatment Landscape with a Focus on Nivolumab + Ipilimumab
Satoshi Ikeda (Kanagawa Cardiovascular and Respiratory Center, Japan)
|
|
| 11:00-11:30 | SY 7-2 |
Current Achievement and Future Perspective of Genome Profiling by Liquid Biopsy
Naoko Aragane (Saga University Hospital, Japan)
|
|
| 11:30-12:00 | SY 7-3 |
Imaging Biomarkers in Lung Cancer
Jin Mo Goo (Seoul National University, Korea)
|
|
|
[Luncheon Symposium 03] Lung Cancer 
|
12:00-12:30 Crystal Ballroom 3 |
||
| Chair | Yoon Soo Chang (Yonsei University, Korea) | ||
| 12:00-12:30 | LS 3 |
Transform Treatment Strategy for EGFRm NSCLC Patients from Early to Advanced Stage
In-Jae Oh (Chonnam National University, Korea)
|
|
|
[Symposium 08] Lung Cancer 2 - Additional Treatment: Worthwhile and When |
13:30-15:00 Crystal Ballroom 3 |
||
| Chair | Kye Young Lee (Konkuk University, Korea) | ||
| 13:30-14:00 | SY 8-1 |
Adjuvant Chemotherapy of Completely Resected Stage 1 Non-Small Cell Lung Cancer
Shin Yup Lee (Kyungpook National University, Korea)
|
|
| 14:00-14:30 | SY 8-2 |
Abscopal Effect of Radiotherapy Combined with Immune Checkpoint Inhibitors
Chang Dong Yeo (The Catholic University of Korea, Korea)
|
|
| 14:30-15:00 | SY 8-3 |
Salvage Surgery for Non-Small Cell Lung Cancer After Tyrosine Kinase Inhibitor Treatment
Chaeuk Chung (Chungnam National University, Korea)
|
|
|
[Symposium 09] Lung Cancer 3 - Beyond Standard Treatment |
15:30-17:00 Crystal Ballroom 3 |
||
| Chair | Seung Joon Kim (The Catholic University of Korea, Korea) | ||
| 15:30-16:00 | SY 9-1 |
The Emerging Therapeutic Landscape of ALK TKIs in Advanced NSCLC
Herbert Loong (The Chinese University of Hong Kong, Hong Kong)
|
|
| 16:00-16:30 | SY 9-2 |
Immune Checkpoint Inhibitors in NSCLC with Driver Mutations
Seung Yong Park (Jeonbuk National University, Korea)
|
|
| 16:30-17:00 | SY 9-3 |
Management of Brain Metastasis Considering Molecular Profiling
James Chih-Hsin Yang (National Taiwan University Cancer Center, Taiwan)
|
|